Vorapaxar in secondary prevention: where we stand.

@article{Kei2017VorapaxarIS,
  title={Vorapaxar in secondary prevention: where we stand.},
  author={Anastazia Kei and Moses S Elisaf},
  journal={Current medical research and opinion},
  year={2017},
  volume={33 11},
  pages={2077-2079}
}
This editorial accompanies an original article being published by the Current Medical Research and Opinion (CMRO) journal, entitled “State transition model: vorapaxar added to standard antiplatelet therapy to prevent thrombosis post myocardial infarction or peripheral artery disease”. In this editorial we consider some aspects of the use of vorapaxar in… CONTINUE READING